Business

Roche pens $2.5B pact for Hanmi’s clinical-stage obesity drug targeting less-explored mechanism - Fierce Biotech

F

Published by FierceBiotech By James Waldron · 24 August 2026 at 11:42

Roche pens $2.5B pact for Hanmi’s clinical-stage obesity drug targeting less-explored mechanism - Fierce Biotech — Image · FierceBiotech

What the report says

Roche has taken its obesity strategy into uncharted territory via a

Read the full report at FierceBiotech →

Loading debate for this article…

Other publishers covering this story

No additional verified coverage is currently clustered with this report.

More stories by this journalist

Other publications from this journalist — open any story without leaving the article page.

No other published stories from this publisher yet.

Related reporting